Global Longlife Hospital Live Share Price Today, Share Analysis and Chart

Name: Global Longlife Hospital and Research Ltd.: Is Infosys Ltd. worth buying?
Item: Global Longlife Hospital and Research Ltd.
Rating: 1.82783325
Author: Trendlyne DVM scores

about

Global Longlife Hospital & Research the company went public in 2022 and provides comprehensive healthcare through a team of full-time and consultant doctors, supported by nursing, paramedical, and support staff.

16.01 -0.64 (-3.84%)

51.51% Fall from 52W High

19,000

BSE Volume

BSE 06 Mar, 2026 1:44 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Not Eligible

Mid Valuation

- / 100

Technically Bearish

31.8 / 100

No estimates available

Global Longlife Hospital Live Price Chart

Loading Fundamental data..

Loading data..

VOTE: Is Global Longlife Hospital and Research Ltd. worth buying?

2 Votes:

Buy 100.0%

Global Longlife Hospital Live Share Price Today, Share Analysis and Chart

Global Longlife Hospital & Research the company went public in 2022 and provides comprehensive healthcare through a team of full-time and consultant doctors, supported by nursing, paramedical, and support staff.

51.51% Fall from 52W High

SWOT Analysis

Global Longlife Hospital Live Price Chart